![OptimizeRx Corporation](/common/images/company/N_OPRX.png)
OptimizeRx Corporation (OPRX)
NASDAQ
The current OPRX market cap is 205.72M. The company's latest EPS is USD -0.9615 and P/E is -11.70.
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 13M | 13.82M | 16.33M | 28.37M | 19.69M |
Operating Income | -7.06M | -4.88M | -3.55M | -8.76M | -5.03M |
Net Income | -6.4M | -4.16M | -2.87M | -4.14M | -6.9M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 24.6M | 43.31M | 61.29M | 62.45M | 71.52M |
Operating Income | -3.69M | -2.14M | 361k | -12.29M | -24.26M |
Net Income | -3.14M | -2.21M | 378k | -11.44M | -17.57M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 131.69M | 121.33M | 123.93M | 183.37M | 176.37M |
Total Liabilities | 7.73M | 5.51M | 7.82M | 56.82M | 53.83M |
Total Equity | 123.96M | 115.82M | 116.11M | 126.55M | 122.54M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 56.64M | 60.33M | 140.99M | 134.65M | 183.37M |
Total Liabilities | 11.78M | 10.35M | 9.61M | 8.54M | 56.82M |
Total Equity | 44.86M | 49.97M | 131.38M | 126.11M | 126.55M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -86k | -2.46M | -982k | -7.24M | 2.12M |
Investing | -1.55M | 1.67M | 664k | -25.34M | -153k |
Financing | -130k | -7.62M | -7.97M | 28.22M | -640k |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -1.66M | -6.31M | 726k | 10.65M | -7.24M |
Investing | -10.58M | -125k | -486k | -58.18M | -25.34M |
Financing | 22.18M | -1.9M | 73.93M | -18.95M | 28.22M |
Market Cap | 205.72M |
Price to Earnings Ratio | -11.70 |
Price to Sales Ratio | 2.87 |
Price to Cash Ratio | 14.84 |
Price to Book Ratio | 1.62 |
Dividend Yield | - |
Shares Outstanding | 18.27M |
Average Volume (1 week) | 145.97k |
Average Volume (1 Month) | 107.93k |
52 Week Change | -18.99% |
52 Week High | 16.645 |
52 Week Low | 6.92 |
Spread (Intraday) | 1.38 (10.93%) |
Company Name | OptimizeRx Corporation |
Address |
4955 s. durango dr las vegas, nevada 89113 |
Website | https://www.optimizerx.com |
Industry | business services, nec (7389) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.